Stage 4B Ovarian Cancer with Lung Metastasis and Ascites Resolved

One and a half years ago, Mrs. Jumariati experienced coughing up blood due to ovarian cancer that had spread to her lungs. She also suffered from abdominal swelling caused by fluid accumulation in the abdomen (ascites) and massive pleural effusion in the lungs. She underwent chemotherapy treatment. After chemotherapy and insertion of drainage tubes, the ascitic fluid reduced and her abdomen became less swollen.

However, despite undergoing five cycles of chemotherapy over four months, the cancer continued to grow. The ovarian tumor increased from 6cm to 7 cm to 14 cm, while the lung tumors enlarged from 2–3 cm to 5–6 cm. Within less than six months, the tumors had more than doubled in size. The cancer characteristics were consistent with a highly aggressive malignancy, and biopsy results later confirmed high-grade serous cell carcinoma.

Because the cancer had already spread to the lungs, surgery was initially not possible, and chemotherapy remained the only medical option. Unfortunately, chemotherapy was no longer effective. At that time, Mrs. Jumariati’s remaining option was ECCT therapy.

Mrs. Jumariati began using the ECCT device in late 2024. Gradually, her condition improved. Her appetite returned, and her coughing and shortness of breath progressively subsided. The coughing up of blood stopped within two weeks of starting ECCT.

During treatment, she expelled large amounts of white mucus, sometimes mixed with thick yellow mucus, believed to be part of the shedding process of cancer cells in the lungs. She also experienced frequent gas, clear foamy urine without strong odor, and urination almost every hour during the first 2–3 months of use.

At the beginning of therapy, she developed fever-like symptoms similar to a viral infection. Overtime, her overall condition improved significantly. Within less than three months, she resumed routine household activities such as mopping floors, cooking daily meals, and preparing weekly meals for Friday charity events. In less than six months, she was able to return to offline teaching activities on campus.

Fortunately, the lung lesions had become relatively clear and there was no longer pleural effusion, allowing doctors to proceed with surgery on the ovarian tumor. Mrs. Jumariati underwent three cycles of chemotherapy before surgery and another three afterward. The ovarian tumor was successfully removed without adhesions. Using ECCT for 2–3 months before surgery may help reduce adhesions in ovarian cancer cases and allow cleaner surgical removal. She continued using ECCT afterward for recurrence prevention and general health support.

The surgical pathology confirmed high-grade serous cell carcinoma, an aggressive form of ovarian cancer. HGSC with lung metastasis commonly causes massive pleural effusion and ascites and is generally classified as advanced stage IVB disease. Standard treatment in such cases is usually palliative, focusing on symptom relief such as draining fluid from the lungs and abdomen. Prognosis is generally poor, with reported average survival ranging from 7–23 months, and achieving remission is considered very difficult.

Mrs. Jumariati eventually transitioned from a palliative condition to a curative state, becoming cancer-free and returning to normal daily life. At present, Mrs. Jumariati is described as being in good health, carrying out normal daily activities, and having remained well 1.5 years after beginning ECCT therapy, or approximately two years after being diagnosed with Stage 4B Ovarian Cancer.